| 6323 |
Centers for Disease Control and Prevention |
Html |
en |
The predicted impact of heart disease prevention and treatment initiatives on mortality in Lithuania, a middle-income country. |
null |
| stable heart disease | 0.594529 |
| composite potential PPD | 0.566997 |
| data | 0.559187 |
| chronic heart disease | 0.570765 |
| LVEF | 0.560259 |
| symptomatic heart disease | 0.758192 |
| acute events | 0.580905 |
| Lithuanian mortality registry | 0.557087 |
| potentially postponable deaths | 0.655985 |
| heart failure | 0.593725 |
| blood pressure | 0.58533 |
| plausible range | 0.720694 |
| patients | 0.578828 |
| analysis | 0.56858 |
| composite PPD | 0.606101 |
| population | 0.601629 |
| upper bound PPD | 0.563707 |
| death rates | 0.577177 |
| blood pressure level | 0.571346 |
| unstable angina | 0.563782 |
| intervention | 0.561149 |
| United States | 0.655033 |
| PPD | 0.616725 |
| adequate physical activity | 0.619652 |
|
| out-of-hospital cardiac arrest | 0.591592 |
| ambulatory setting | 0.563024 |
| lower bound PPD | 0.564267 |
| Kaunas University Hospital | 0.593992 |
| maximum plausible PPD | 0.578429 |
| total mortality | 0.568704 |
| heart disease | 0.926116 |
| acute heart failure | 0.575845 |
| acute cardiac events | 0.559352 |
| Lithuanian population | 0.565199 |
| cardiovascular disease | 0.565659 |
| angina/other heart disease | 0.564242 |
| largest PPD | 0.614955 |
| people | 0.573757 |
| apparent heart disease | 0.743981 |
| heart disease risk | 0.575869 |
| mortality rate | 0.571757 |
| heart disease prevention | 0.595801 |
| Thomas E. Kottke | 0.562974 |
| interventions | 0.565077 |
| heart disease continuum | 0.572715 |
| mortality | 0.614966 |
| ventricular ejection fraction | 0.558535 |
| coronary heart disease | 0.590391 |
|
CLICK HERE |
| 7490 |
Centers for Disease Control and Prevention |
Html |
en |
Veterans Health Activities - Gulf War Studies |
CDC's National Center for Environmental Health (NCEH) has taken the lead for HHS in addressing the health concerns of veterans of the Vietnam War and the Gulf War, and NCEH is working with the Departments of Defense and Veterans Affairs to protect the health of our future military forces. |
| MPEG | 0.741242 |
| site | 0.541063 |
| PDF | 0.544429 |
|
|
CLICK HERE |
| 8518 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Retailer Adherence to Family Smoking Prevention and Tobacco Control Act, North Carolina, 2011 -CDC |
The Family Smoking Prevention and Tobacco Control Act regulates the sales and marketing of tobacco products in the United States; poor adherence by tobacco retailers may reduce the effectiveness of the Act’s provisions. The objectives of this study were 1) to assess whether and to which provisions retailers were adherent and 2) to examine differences in adherence by county, retailer neighborhood, and retailer characteristics. |
| North Carolina | 0.733301 |
| new retailers | 0.49701 |
| nonadherent retailers | 0.495081 |
| New Hanover County | 0.527944 |
| Tobacco Control Act | 0.994499 |
| new provisions | 0.483149 |
| eligible retailers | 0.499377 |
| point-of-sale sales provisions | 0.499712 |
| Tobacco control state | 0.510833 |
| potential tobacco retailers | 0.580577 |
| tobacco store | 0.492799 |
| tobacco audit | 0.489337 |
| retailer type | 0.501663 |
| point-of-sale provisions | 0.663156 |
| selling tobacco | 0.492497 |
| Act point-of-sale provisions | 0.535866 |
| certain tobacco products | 0.52462 |
| differential adherence | 0.48621 |
| grocery stores | 0.554179 |
| Hanover County retailers | 0.549954 |
| tobacco products | 0.700451 |
| roll-your-own tobacco | 0.501875 |
| retailer neighborhood characteristics | 0.644422 |
| drug stores | 0.517837 |
| Tobacco Products Scientific | 0.505832 |
|
| cigarettes | 0.507701 |
| Family Smoking Prevention | 0.524733 |
| study | 0.506778 |
| tobacco sales | 0.49992 |
| convenience stores | 0.490249 |
| Durham County retailers | 0.571282 |
| New Hanover retailers | 0.508014 |
| tobacco advertising | 0.498223 |
| tobacco stores | 0.5063 |
| racial/ethnic minority | 0.494934 |
| tobacco vending machines | 0.544186 |
| retailer characteristics | 0.502647 |
| Buncombe County retailers | 0.541203 |
| tobacco marketing | 0.483306 |
| tobacco retailers | 0.758497 |
| retailer adherence | 0.514504 |
| new Tobacco Control | 0.530809 |
| federal poverty guidelines | 0.563608 |
| adherence | 0.587579 |
| provisions retailers | 0.564813 |
| smokeless tobacco products | 0.565844 |
| tobacco brand–name event | 0.50935 |
| smokeless tobacco | 0.656321 |
| North Carolina counties | 0.536135 |
|
CLICK HERE |
| 9746 |
Centers for Disease Control and Prevention |
Html |
en |
Histoplasmosis in a State Where It Is Not Known to BeEndemic - Montana, 2012-2013 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| H. capsulatum disease | 0.516363 |
| recent travel | 0.597998 |
| Human Services | 0.41911 |
| H. capsulatum isolation | 0.510559 |
| left parotid gland | 0.416294 |
| clinically compatible illnesses | 0.552003 |
| south central Montana | 0.434153 |
| Clark City-County Health | 0.473448 |
| bird droppings | 0.46623 |
| itraconazole therapy | 0.459042 |
| histoplasmosis | 0.600608 |
| Ohio River | 0.453218 |
| H. capsulatum culture | 0.514061 |
| follow-up urine EIA | 0.422329 |
| Montana | 0.595046 |
| patients | 0.445152 |
| weight loss | 0.470078 |
| lymph node biopsy | 0.404272 |
| endemic fungal infections | 0.40455 |
| histoplasmosis endemicity | 0.514951 |
| Randall J. Nett | 0.460003 |
| left lung nodule | 0.406064 |
| City-County Health Dept | 0.476656 |
| uncontrolled diabetes mellitus | 0.481258 |
| bat guano | 0.73612 |
|
| diabetes mellitus type | 0.480428 |
| night sweats | 0.407169 |
| Montana residents | 0.437226 |
| Histoplasma capsulatum | 0.528464 |
| parotid gland | 0.44523 |
| recent travel history | 0.419486 |
| diagnostic delays | 0.429165 |
| Health-care providers | 0.443149 |
| patient | 0.652634 |
| urine histoplasma antigen | 0.432039 |
| southwest Montana | 0.440009 |
| bat guano exposure | 0.427909 |
| H. capsulatum | 0.962684 |
| granulomatous inflammation | 0.408922 |
| CT scan | 0.431381 |
| erythrocyte sedimentation rate | 0.462822 |
| H. capsulatum infection | 0.524406 |
| lower lung | 0.414034 |
| urine EIA | 0.446921 |
| common clinical presentation | 0.409187 |
| Low clinical suspicion | 0.406632 |
| urine EIA tests | 0.409679 |
| fungus Histoplasma capsulatum | 0.493899 |
| chest radiograph | 0.413869 |
|
CLICK HERE |
| 10725 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Multiple Chronic Conditions Among US Adults: A 2012 Update - CDC |
The objective of this research was to update earlier estimates of prevalence rates of single chronic conditions and multiple (>2) chronic conditions (MCC) among the noninstitutionalized, civilian US adult population. Data from the 2012 National Health Interview Survey (NHIS) were used to generate estimates of MCC for US adults and by select demographic characteristics. Approximately half (117 million) of US adults have at least one of the 10 chronic conditions examined (ie, hypertension, coronary heart disease, stroke, diabetes, cancer, arthritis, hepatitis, weak or failing kidneys, current asthma, or chronic obstructive pulmonary disease [COPD]). Furthermore, 1 in 4 adults has MCC. |
| Family Core | 0.664968 |
| state-sponsored health plans | 0.660267 |
| health care provider | 0.669072 |
| Prev Chronic Dis | 0.829776 |
| National Health Interview | 0.829361 |
| non-Hispanic Asian adults | 0.670197 |
| multiple chronic conditions | 0.802044 |
| prevalence rates | 0.658045 |
| Health Insurance Program | 0.662689 |
| Disease Control | 0.664444 |
| Sample Adult Core | 0.654403 |
| public health systems | 0.665516 |
| health care providers | 0.664373 |
| health insurance coverage | 0.855923 |
| multistage health survey | 0.676458 |
| Vital Health Stat | 0.684352 |
| non-Hispanic black adults | 0.670252 |
| Health Interview Survey | 0.831106 |
| MCC prevalence | 0.710882 |
| national health surveys | 0.666836 |
| Summary health statistics | 0.695035 |
| insurance coverage status | 0.652436 |
| chronic bronchitis | 0.674976 |
| Chronic Disease | 0.6709 |
| obstructive pulmonary disease | 0.655406 |
|
| Public health insurance | 0.665421 |
| United States | 0.709258 |
| adults | 0.768261 |
| prevalence estimates | 0.658394 |
| earlier estimates | 0.660227 |
| military health plans | 0.660098 |
| public health concern | 0.664994 |
| public health | 0.737428 |
| health care | 0.674012 |
| non-Hispanic white adults | 0.670271 |
| Mental health conditions | 0.684357 |
| sample adult | 0.679524 |
| MCC | 0.755341 |
| NHIS Core questionnaires | 0.651475 |
| chronic conditions | 0.977276 |
| different conditions | 0.65173 |
| NHIS Family Core | 0.661626 |
| public health problem | 0.676722 |
| Public Health Service | 0.662564 |
| single chronic conditions | 0.789971 |
| Goodman RA | 0.664088 |
| select demographic characteristics | 0.651355 |
| coronary heart disease | 0.78866 |
| Public Health Rep | 0.662394 |
|
CLICK HERE |
| 11000 |
Centers for Disease Control and Prevention |
Html |
en |
What Do Parents Need to Know to Protect Their Children? - New Blood Lead Level Information |
Protecting children from exposure to lead is important to lifelong good health. Even low levels of lead in blood have been shown to affect IQ, ability to pay attention, and academic achievement. And effects of lead exposure cannot be corrected. |
| CDC | 0.49559 |
| micrograms | 0.514803 |
| new level | 0.500072 |
| chelation therapy | 0.511382 |
| 97.5th percentile | 0.608357 |
| reference level | 0.503245 |
| concern | 0.433901 |
| private health insurance | 0.570973 |
| children’s levels | 0.518737 |
| case management | 0.494943 |
| major diseases | 0.493454 |
| children | 0.973087 |
| low levels | 0.501929 |
| Nutrition Examination Survey | 0.576291 |
| test result | 0.694635 |
| high blood lead | 0.609157 |
| risk factors | 0.49353 |
| population-based survey | 0.498304 |
| recent NHANES surveys | 0.579069 |
| new recommendation | 0.497066 |
| public health officials | 0.564994 |
| future exposure | 0.521978 |
| National Health | 0.498163 |
| safe blood lead | 0.637153 |
| doctors | 0.43537 |
|
| reference value | 0.831098 |
| current reference value | 0.579499 |
| lead exposure | 0.966973 |
| new lower value | 0.563608 |
| medical treatment | 0.607526 |
| academic achievement | 0.502669 |
| Experts | 0.440577 |
| United States | 0.496906 |
| blood lead test | 0.616276 |
| important step parents | 0.580286 |
| new NHANES data | 0.571128 |
| blood lead | 0.927224 |
| deciliter | 0.514765 |
| primary prevention | 0.516763 |
| children’s blood | 0.558501 |
| NHANES data | 0.652094 |
| nutritional status | 0.494362 |
| good health | 0.503991 |
| blood test | 0.578888 |
| dangerous lead sources | 0.638516 |
| U.S. population | 0.498207 |
| blood lead level | 0.729871 |
| simple steps | 0.505472 |
| blood lead distribution | 0.618796 |
|
CLICK HERE |
| 12371 |
Centers for Disease Control and Prevention |
Image |
null |
Lung Cancer in African-American Men (600W x 2140H) |
null |
|
|
CLICK HERE |
| 13733 |
Centers for Disease Control and Prevention |
Image |
null |
Percentage of babies breastfeeding during the first year |
null |
|
|
CLICK HERE |
| 15274 |
Centers for Disease Control and Prevention |
Html |
en |
NIOSH Publications and Products - Injuries and Amputations Resulting from Work with Mechanical Power Presses (87-107) |
null |
| foot control | 0.216648 |
| foot controls | 0.223975 |
| hand speed | 0.335017 |
| point | 0.211225 |
| Occupational Safety | 0.224963 |
| dual palm-button controls | 0.300058 |
| palm buttons | 0.727145 |
| dual palm buttons | 0.704203 |
| male press operators | 0.317538 |
| safety | 0.255308 |
| power press operators | 0.63561 |
| mechanical power presses | 0.974373 |
| OSHA standards | 0.219886 |
| foot | 0.265253 |
| hand speeds | 0.221378 |
|
| part-revolution clutches | 0.241431 |
| cycling rate | 0.258985 |
| young male press | 0.308869 |
| critical cycling rate | 0.258611 |
| operator hand speeds | 0.201424 |
| individual press operators | 0.201028 |
| young male operators | 0.23008 |
| mechanical power press | 0.525074 |
| mechanical press operators | 0.244905 |
| press operators | 0.759574 |
| OSHA | 0.316264 |
| safety distance | 0.222783 |
| power press injuries | 0.200283 |
| foot-activated power presses | 0.210009 |
| operation | 0.282371 |
|
CLICK HERE |
| 15278 |
Centers for Disease Control and Prevention |
Html |
en |
For Clinicians: Evaluating and Managing Patients Exposed to Birds Infected with Avian Influenza Viruses of Public Health Concern |
A fact sheet for clinicians that gives guidance on evaluating and managing patients exposed to birds infected with HPAI H5 - CDC |
| avian influenza | 0.90155 |
| molecular testing | 0.301218 |
| infected birds | 0.282877 |
| domestic poultry | 0.280892 |
| infection control guidance | 0.316193 |
| respiratory tract specimens | 0.277766 |
| AI virus | 0.414752 |
| public health risk | 0.271682 |
| influenza A virus | 0.428818 |
| Health care personnel | 0.278312 |
| respiratory specimens | 0.276799 |
| personal protective equipment | 0.271976 |
| infection isolation room | 0.31686 |
| Avian Influenza Guidance | 0.393767 |
| influenza virus infections | 0.381307 |
| enterically administered oseltamivir | 0.27269 |
| AI virus infection | 0.370322 |
| highly-pathogenic avian influenza | 0.403036 |
| severe disease | 0.381415 |
| pandemic potential | 0.278185 |
| particular public health | 0.275181 |
| visit Infection | 0.281355 |
| neuraminidase inhibitor treatment | 0.272731 |
| low-pathogenic avian influenza | 0.402763 |
|
| wild aquatic birds | 0.284098 |
| avian influenza viruses | 0.838244 |
| novel influenza | 0.454029 |
| infection control | 0.335491 |
| novel avian influenza | 0.400553 |
| Cause Severe Disease | 0.280092 |
| Laboratory testing recommendations | 0.278473 |
| influenza virus infection | 0.491978 |
| associated AI outbreak | 0.289657 |
| important clinical information | 0.282888 |
| upper respiratory tract | 0.342096 |
| sore throat | 0.275057 |
| public health concern | 0.560604 |
| illness | 0.295957 |
| antiviral treatment decisions | 0.284109 |
| avian influenza virus | 0.547367 |
| poultry outbreak response | 0.279027 |
| AI viruses | 0.447035 |
| infection prevention | 0.319421 |
| antiviral treatment | 0.335627 |
| neuraminidase inhibitor | 0.277811 |
| respiratory tract signs | 0.278962 |
| additional respiratory specimens | 0.274766 |
| Influenza A Viruses | 0.470374 |
|
CLICK HERE |